Xin chia sẻ danh mục thuốc hết bản quyền và sắp có đạng generic trên thị trường.
Drug Patent Expirations for May 2014 |
|||
| Tradename | Applicant | Generic Name | Patent No. |
RYZOLT
|
Purdue Pharma
|
tramadol hydrochloride
|
6,254,887 |
RYZOLT
|
Purdue Pharma
|
tramadol hydrochloride
|
5,591,452 |
TRITEC
|
Glaxosmithkline
|
ranitidine bismuth citrate
|
5,629,297 |
THALOMID
|
Celgene
|
thalidomide
|
5,629,327 |
IMAGENT
|
Imcor Pharms Co
|
dimyristoyl lecithin; perflexane
|
5,626,833 |
RESTASIS
|
Allergan
|
cyclosporine
|
5,474,979 |
CHILDREN'S ALLEGRA ALLERGY
|
Sanofi Aventis Us
|
fexofenadine hydrochloride
|
7,138,524 |
CHILDREN'S ALLEGRA HIVES
|
Sanofi Aventis Us
|
fexofenadine hydrochloride
|
7,138,524 |
NATRECOR
|
Scios Llc
|
nesiritide recombinant
|
5,114,923 |
RISPERDAL CONSTA
|
Janssen Pharms
|
risperidone
|
6,110,921*PED |
RISPERDAL CONSTA
|
Janssen Pharms
|
risperidone
|
7,547,452*PED |
KALETRA
|
Abbvie
|
lopinavir; ritonavir
|
5,886,036*PED |
RISPERDAL CONSTA
|
Janssen Pharms
|
risperidone
|
5,965,168*PED |
RISPERDAL CONSTA
|
Janssen Pharms
|
risperidone
|
6,368,632*PED |
LUPRON DEPOT
|
Abbvie Endocrine Inc
|
leuprolide acetate
|
5,631,020 |
LUPRON DEPOT
|
Abbvie Endocrine Inc
|
leuprolide acetate
|
5,631,021 |
LUPRON DEPOT-PED
|
Abbvie Endocrine Inc
|
leuprolide acetate
|
5,631,020 |
ZINGO
|
Powder Pharms
|
lidocaine hydrochloride
|
5,630,796 |
INOMAX
|
Ino
|
nitric oxide
|
5,558,083*PED |
TAXOTERE
|
Sanofi Aventis Us
|
docetaxel
|
5,438,072*PED |
COPAXONE
|
Teva Pharms Usa
|
glatiramer acetate
|
6,362,161 |
COPAXONE
|
Teva Pharms Usa
|
glatiramer acetate
|
7,199,098 |
COPAXONE
|
Teva Pharms Usa
|
glatiramer acetate
|
6,939,539 |
COPAXONE
|
Teva Pharms Usa
|
glatiramer acetate
|
6,342,476 |
COPAXONE
|
Teva Pharms Usa
|
glatiramer acetate
|
5,981,589 |
COPAXONE
|
Teva Pharms Usa
|
glatiramer acetate
|
6,054,430 |
COPAXONE
|
Teva Pharms Usa
|
glatiramer acetate
|
6,620,847 |
COPAXONE
|
Teva Pharms Usa
|
glatiramer acetate
|
8,367,605 |
MALARONE
|
Glaxosmithkline
|
atovaquone; proguanil hydrochloride
|
5,998,449*PED |
MALARONE
|
Glaxosmithkline
|
atovaquone; proguanil hydrochloride
|
6,291,488*PED |
MALARONE PEDIATRIC
|
Glaxosmithkline
|
atovaquone; proguanil hydrochloride
|
6,166,046*PED |
MALARONE
|
Glaxosmithkline
|
atovaquone; proguanil hydrochloride
|
6,166,046*PED |
MALARONE PEDIATRIC
|
Glaxosmithkline
|
atovaquone; proguanil hydrochloride
|
5,998,449*PED |
MALARONE PEDIATRIC
|
Glaxosmithkline
|
atovaquone; proguanil hydrochloride
|
6,291,488*PED |
ALLEGRA
|
Sanofi Aventis Us
|
fexofenadine hydrochloride
|
5,578,610*PED |
NAROPIN
|
Fresenius Kabi Usa
|
ropivacaine hydrochloride
|
5,834,489 |
CHILDREN'S ALLEGRA HIVES
|
Sanofi Aventis Us
|
fexofenadine hydrochloride
|
5,578,610*PED |
ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
|
Sanofi Aventis Us
|
fexofenadine hydrochloride; pseudoephedrine
hydrochloride
|
5,578,610*PED |
ALLEGRA ALLERGY
|
Sanofi Aventis Us
|
fexofenadine hydrochloride
|
5,578,610*PED |
CHILDREN'S ALLEGRA ALLERGY
|
Sanofi Aventis Us
|
fexofenadine hydrochloride
|
5,578,610*PED |
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION
|
Sanofi Aventis Us
|
fexofenadine hydrochloride; pseudoephedrine
hydrochloride
|
5,578,610*PED |
ALLEGRA HIVES
|
Sanofi Aventis Us
|
fexofenadine hydrochloride
|
5,578,610*PED |
SPORANOX
|
Janssen Pharms
|
itraconazole
|
5,633,015 |
NEXIUM IV
|
Astrazeneca
|
esomeprazole sodium
|
6,143,771 |
RECTIV
|
Aptalis Pharma
|
nitroglycerin
|
7,189,761 |
NORDITROPIN
|
Novo Nordisk Inc
|
somatropin recombinant
|
5,633,352 |
CELEBREX
|
Gd Searle
|
celecoxib
|
5,563,165*PED |
CELEBREX
|
Gd Searle
|
celecoxib
|
5,466,823*PED |
ERTACZO
|
Valeant Luxembourg
|
sertaconazole nitrate
|
5,135,943 |
| Drug Patent Expirations for the week of October 20, 2013 | |||
| Tradename | Applicant | Generic Name | Patent No. |
| LOTEMAX | Pharmos | oteprednol etabonate | 5,540,930 |
| Drug Patent Expirations for the week of October 27, 2013 | |||
| Tradename | Applicant | Generic Name | Patent No. |
| MACUGEN | Valeant Pharms Llc | pegaptanib sodium | 6,113,906 |
| MACUGEN | Valeant Pharms Llc | pegaptanib sodium | 5,919,455 |
| BACTROBAN | Glaxosmithkline | mupirocin calcium | 5,569,672 |
| YAZ | Bayer Hlthcare | drospirenone; ethinyl estradiol | 5,569,652 |
| YASMIN | Bayer Hlthcare | drospirenone; ethinyl estradiol | 5,569,652 |
| SAMSCA | Otsuka America Pharm | tolvaptan | 5,258,510 |
| Drug Patent Expirations for the week of November 3, 2013 | |||
| Tradename | Applicant | Generic Name | Patent No. |
| PROPECIA | Merck | finasteride | 5,571,817 |
| ACIPHEX SPRINKLE | Eisai Inc | rabeprazole sodium | 5,045,552*PED |
| ACIPHEX | Eisai Inc | rabeprazole sodium | 5,045,552*PED |
| Drug Patent Expirations for the week of December 8, 2013 | |||
| Tradename | Applicant | Generic Name | Patent No. |
| EMADINE | Alcon | emedastine difumarate | 5,441,958 |
| ENTEREG | Cubist Pharms | alvimopan | 5,434,171 |
| EDARBI | Arbor Pharms Llc | azilsartan kamedoxomil | 5,583,141 |
| SOLAGE | Aqua Pharms | mequinol; tretinoin | 5,194,247 |
| EDARBYCLOR | Arbor Pharms Llc | azilsartan kamedoxomil; chlorthalidone | 5,583,141 |
| CYMBALTA | Lilly | duloxetine hydrochloride | 5,023,269*PED |
| ABREVA | Glaxosmithkline | docosanol | 5,534,554 |
| LUPRON DEPOT-PED | Abbvie Endocrine Inc | leuprolide acetate | 6,036,976 |
| Drug Patent Expirations for the week of January 26, 2014 | |||
| Tradename | Applicant | Generic Name | Patent No. |
| XYZAL | Ucb Inc | levocetirizine dihydrochloride | 5,698,558*PED |
| DULERA | Merck Sharp Dohme | formoterol fumarate; mometasone furoate | 6,677,323 |
| NORVIR | Abbott | ritonavir | 5,541,206*PED |
| NORVIR | Abbvie | ritonavir | 5,635,523*PED |
| KALETRA | Abbvie | lopinavir; ritonavir | 5,541,206*PED |
| NORVIR | Abbvie | ritonavir | 5,541,206*PED |
| NORVIR | Abbvie | ritonavir | 5,674,882*PED |
| BETAXON | Alcon Pharms Ltd | levobetaxolol hydrochloride | 5,540,918*PED |
| Drug Patent Expirations for the week of February 2, 2014 | |||
| Tradename | Applicant | Generic Name | Patent No. |
| LEVEMIR | Novo Nordisk Inc | insulin detemir recombinant | 6,011,007 |
| LEVEMIR FLEXPEN | Novo Nordisk Inc | insulin detemir recombinant | 6,011,007 |
| LEVEMIR INNOLET | Novo Nordisk Inc | insulin detemir recombinant | 6,011,007 |
| LEVEMIR PENFILL | Novo Nordisk Inc | insulin detemir recombinant | 6,011,007 |
| LEVEMIR | Novo Nordisk Inc | insulin detemir recombinant | 6,869,930 |
| LEVEMIR FLEXPEN | Novo Nordisk Inc | insulin detemir recombinant | 6,869,930 |
| LEVEMIR INNOLET | Novo Nordisk Inc | insulin detemir recombinant | 6,869,930 |
| LEVEMIR PENFILL | Novo Nordisk Inc | insulin detemir recombinant | 6,869,930 |
| CEDAX | Pernix Therap | ceftibuten dihydrate | 5,599,557 |
| ELIGARD | Tolmar Therap | leuprolide acetate | 5,599,552 |
| Drug Patent Expirations for April 2014 | |||
| Tradename | Applicant | Generic Name | Patent No. |
| MAXALT-MLT | Merck | rizatriptan benzoate | 5,457,895*PED |
| ABELCET | Sigma Tau | amphotericin b | 5616334 |
| FROVA | Endo Pharms | frovatriptan succinate | 5616603 |
| BROVANA | Sunovion | arformoterol tartrate | 6589508 |
| INCRELEX | Ipsen Inc | mecasermin recombinant | 6207640 |
| VIRACEPT | Agouron | nelfinavir mesylate | 5,952,343*PED |
| NIZORAL A-D | Mcneil Cons | ketoconazole | 5456851 |
| VIRACEPT | Agouron | nelfinavir mesylate | 5,484,926*PED |
| VIRACEPT | Agouron | nelfinavir mesylate | 6,162,812*PED |
| INVEGA SUSTENNA | Janssen Pharms | paliperidone palmitate | 5,254,556*PED |
| ATELVIA | Warner Chilcott Llc | risedronate sodium | 5622721 |
| ALREX | Bausch And Lomb | loteprednol etabonate | 5,747,061*PED |
| LOTEMAX | Bausch And Lomb | loteprednol etabonate | 5,747,061*PED |
| ZYLET | Bausch And Lomb | loteprednol etabonate; tobramycin | 5,747,061*PED |
| ALREX | Bausch And Lomb | loteprednol etabonate | 5,540,930*PED |
| LOTEMAX | Bausch And Lomb | loteprednol etabonate | 5,540,930*PED |
| ZYLET | Bausch And Lomb | loteprednol etabonate; tobramycin | 5,540,930*PED |
| ABREVA | Glaxosmithkline | docosanol | 4874794 |